Bahareh Bahmani, Zahra Amini-bayat, Mohammad Mehdi Ranjbar, Nahid Bakhtiari & Amir-Hassan Zarnani. (2020) HPV16-E7 Protein T Cell Epitope Prediction and Global Therapeutic Peptide Vaccine Design Based on Human Leukocyte Antigen Frequency: An In-Silico Study. International Journal of Peptide Research and Therapeutics 27:1, pages 365-378.
Crossref
Kyuri Lee, Minjeong Kim, Yunmi Seo & Hyukjin Lee. (2018) Development of mRNA vaccines and their prophylactic and therapeutic applications. Nano Research 11:10, pages 5173-5192.
Crossref
Liliane Maria Fernandes de Oliveira, Mirian Galliote Morale, Agatha A. Muniz Chaves, Aline Marques Cavalher, Aline Soriano Lopes, Mariana de Oliveira Diniz, Alessandra Soares Schanoski, Robson Lopes de Melo, Luís Carlos de Souza Ferreira, Maria Leonor S. de Oliveira, Marilene Demasi & Paulo Lee Ho. (2015) Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine. PLOS ONE 10:9, pages e0138686.
Crossref
Kathryn Patton, Shahin Aslam, Jim Lin, Li Yu, Stacie Lambert, Glenn Dawes, Mark T. Esser, Jennifer Woo, Sylvia Janetzki & Anu Cherukuri. (2014) Enzyme-Linked Immunospot Assay for Detection of Human Respiratory Syncytial Virus F Protein-Specific Gamma Interferon-Producing T Cells. Clinical and Vaccine Immunology 21:5, pages 628-635.
Crossref
Axel Hoos. 2014. Cancer Immunotherapy Meets Oncology. Cancer Immunotherapy Meets Oncology
53
62
.
Sjoerd H. van der Burg, Steffen Walter, Sylvia Janetzki, Cedrik Michael Britten, Jérôme Galon, Marij J. P. Welters & Cécile Gouttefangeas. 2014. Cancer Immunotherapy Meets Oncology. Cancer Immunotherapy Meets Oncology
37
51
.
Helene Filbert, Sebastian Attig, Nicole Bidmon, Bernhard Y. Renard, Sylvia Janetzki, Ugur Sahin, Marij J. P. Welters, Christian Ottensmeier, Sjoerd H. van der Burg, Cécile Gouttefangeas & Cedrik M. Britten. (2012) Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols. Cancer Immunology, Immunotherapy 62:4, pages 615-627.
Crossref
Marij J.P. Welters & Sjoerd H. van der Burg. 2013. Cancer Immunotherapy. Cancer Immunotherapy
241
258
.
Sylvia Janetzki, Pedro Romero, Mario Roederer, Diane L. Bolton & Camilla Jandus. 2012. Vaccinology. Vaccinology
417
440
.
Marij J. P. Welters, Cécile Gouttefangeas, Tamara H. Ramwadhdoebe, Anne Letsch, Christian H. Ottensmeier, Cedrik M. Britten & Sjoerd H. van der Burg. (2012) Harmonization of the intracellular cytokine staining assay. Cancer Immunology, Immunotherapy 61:7, pages 967-978.
Crossref
Cedrik Britten, Sylvia Janetzki, Cécile Gouttefangeas, Marij Welters, Michael Kalos, Christian Ottensmeier, Axel Hoos & Sjoerd van der Burg. 2011. Cancer Vaccines. Cancer Vaccines
156
166
.
Cedrik M. Britten, Sylvia Janetzki, Cécile Gouttefangeas, Marij J. P. Welters, Michael Kalos, Christian Ottensmeier, Axel Hoos & Sjoerd H. van der Burg. 2011. Cancer Vaccines: From Research to Clinical Practice. Cancer Vaccines: From Research to Clinical Practice
156
166
.
Darin A. Wick, Spencer D. Martin, Brad H. Nelson & John R. Webb. (2011) Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C). Vaccine 29:5, pages 984-993.
Crossref
Z. Moodie, L. Price, C. Gouttefangeas, A. Mander, S. Janetzki, M. Löwer, M. J. P. Welters, C. Ottensmeier, S. H. van der Burg & Cedrik M. Britten. (2010) Response definition criteria for ELISPOT assays revisited. Cancer Immunology, Immunotherapy 59:10, pages 1489-1501.
Crossref
Shreemanta K. Parida, Isabelle Magalhaes, Patrice Dubois & Sylvia Janetzki. (2010) Training in immunology of relevance to global health issues in resource poor settings. European Journal of Immunology 40:5, pages 1228-1231.
Crossref
A. Mander, C. Gouttefangeas, C. Ottensmeier, M. J. P. Welters, L. Low, S. H. van der Burg & C. M. Britten. (2010) Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program. Cancer Immunology, Immunotherapy 59:4, pages 619-627.
Crossref
Cedrik Michael Britten, Sylvia Janetzki, Leah Ben-Porat, Timothy M. Clay, Michael Kalos, Holden Maecker, Kunle Odunsi, Michael Pride, Lloyd Old, Axel Hoos & Pedro Romero. (2009) Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunology, Immunotherapy 58:10, pages 1701-1713.
Crossref
Michal Lotem, Arthur Machlenkin, Tamar Hamburger, Aviram Nissan, Luna Kadouri, Shoshana Frankenburg, Zvi Gimmon, Orit Elias, Inna Ben David, Anna Kuznetz, Eitan Shiloni & Tamar Peretz. (2009) Autologous Melanoma Vaccine Induces Antitumor and Self-Reactive Immune Responses That Affect Patient Survival and Depend on MHC Class II Expression on Vaccine Cells. Clinical Cancer Research 15:15, pages 4968-4977.
Crossref
Peggy J. de Vos van Steenwijk, Sytse J. Piersma, Marij J.P. Welters, Jeanette M. van der Hulst, Gertjan Fleuren, Bart W.J. Hellebrekers, Gemma G. Kenter & Sjoerd H. van der Burg. (2008) Surgery followed by Persistence of High-Grade Squamous Intraepithelial Lesions Is Associated with the Induction of a Dysfunctional HPV16-Specific T-Cell Response. Clinical Cancer Research 14:22, pages 7188-7195.
Crossref